Publication | Closed Access

Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission

Substance AbusePsychoactive DrugPsychiatryBehavioral NeuroscienceAddictionMedicineBehavioral PharmacologyPsychopharmacologyBrain Monoaminergic NeurotransmissionNeuropharmacologySocial SciencesNeuroscienceDopaminePharmacologyAryl-piperazine Anxiolytic DrugPsychopathologyAggressive Behavior